[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"transaminases\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:transaminases":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":5},"100573503","phase-2-efficacy-of-montelukast-in-preventing-transaminase-elevation-in-adult-dengue-patients-100573503",false,"NCT06747130","Efficacy of Montelukast in Preventing Transaminase Elevation in Adult Dengue Patients","Efficacy of Montelukast in Preventing Transaminase Elevation in Adult Dengue Patients: a Randomized, Double-blind, Placebo Controlled, Superiority Trial","Inclusion Criteria:\n\n* Patient age \\>18 years\n* Dengue infection diagnosed by NS1 antigen, or polymerase chain reaction\n* Admitted to the hospital\n* Written informed consent from patient or attending relative able to and willing to give informed consent\n\nExclusion Criteria:\n\n* Other possible cause of fever other than dengue infection\n* Pregnancy\n* Unable to take medication\n* Aminotransferase level above 150 U\u002Fl\n* Allergy to paracetamol or tramadol\n* Paracetamol indicated for condition other than dengue infection\n* Critically ill patient who need ICU or invasive ventilation support\n* History of cirrhosis\n* Unable to communicate\n* Other indication of montelukast\n* History of psychiatric illness","ALL","20 Years",{"count":19,"type":20},82,"ESTIMATED","INTERVENTIONAL",[23,24],"PHASE2","PHASE3","The goal of this clinical trial is to learn if drug montelukast works to treat dengue in adults. It will also learn about the safety of drug montelukast . The main questions it aims to answer are:\n\nDoes drug montelukast lower the incidence of liver enzyme elevations in participants ? What medical problems do participants have when taking drug montelukast ?",[27,28,29],"Dengue","Montelukast","Transaminases","RECRUITING","2025-05-27",{"date":33,"type":34},"2025-05-29","ACTUAL",{"date":36,"type":34},"2025-01-31",{"date":38,"type":20},"2027-01",{"name":40,"class":41},"Phramongkutklao College of Medicine and Hospital","OTHER"]